Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL.
Babor F, Peters C, Manser AR, Glogova E, Sauer M, Pötschger U, Ahlmann M, Cario G, Feuchtinger T, Gruhn B, Güngör T, Horn PA, Kremens B, Lang P, Mezger M, Müller I, Mytilineos J, Oevermann L, Pichler H, Scherenschlich N, Schuster FR, Siepermann M, Stachel D, Strahm B, Wössmann W, Escherich G, Zimmermann M, Schrappe M, Borkhardt A, Eckert C, Bader P, Uhrberg M, Meisel R.
Babor F, et al. Among authors: kremens b.
Bone Marrow Transplant. 2019 Nov;54(11):1847-1858. doi: 10.1038/s41409-019-0543-z. Epub 2019 May 14.
Bone Marrow Transplant. 2019.
PMID: 31089287
Clinical Trial.